Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), located in Tustin, CA, is a CDMO focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. Avid has over 25 years of experience producing monoclonal antibodies and recombinant proteins. Services include analytical development, process development (upstream and downstream), CGMP clinical and commercial drug substance manufacturing, release and stability testing as well as regulatory submissions support. www.avidbio.com